Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02769546 · ClinicalTrials.gov registry record
Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Terminated
- Registry status
- 50
- Enrollment target
NCT02769546 is a clinical trial that was terminated before completion, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 50 participants.
The verdict
NCT02769546 was terminated before completion, sponsored by Abramson Cancer Center at Penn Medicine.
- TERMINATED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The primary objective is to administer a cross-sectional survey to directly compare the differences patients and physicians hold regarding ovarian cancer prognosis and survival, complications arising from treatment, and counseling on advance directives, living wills, palliative care, and hospice services. Overall, the project will pinpoint opportunities for better patient physician communication regarding prognosis and end-of-life care and allow for more informed and tailored decision-making.
Interventions
- OTHER Surveys
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02769546
The ClinicalTrials.gov registry entry for NCT02769546 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Surveys is the first listed.
NCT02769546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02769546 about?
NCT02769546 is a clinical study titled "Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis". The primary objective is to administer a cross-sectional survey to directly compare the differences patients and physicians hold regarding ovarian cancer prognosis and survival, complications arising from treatment, and counseling on advance directives, living wills, palliative care, and hospice ser...
What is the current status of trial NCT02769546?
This trial is currently terminated. The enrollment target is 50 participants. The study started on 2016-01. Estimated completion is 2018-01.
What interventions are being tested in trial NCT02769546?
The interventions under investigation include: Surveys (OTHER).
Who is sponsoring clinical trial NCT02769546?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.